Corrigendum: Guanxin Danshen formulation protects against myocardial ischemia reperfusion injury-induced left ventricular remodeling by upregulating estrogen receptor β

[This corrects the article DOI: 10.3389/fphar.2017.00777.].

Saved in:

Bibliographic Details
Published in:	Frontiers in pharmacology Vol. 15; p. 1488968
Main Authors:	Deng, Xuehong, Xing, Xiaoyan, Sun, Guibo, Xu, Xudong, Wu, Haifeng, Li, Guang, Sun, Xiaobo
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 08-10-2024
Subjects:	estrogen receptor β Guanxin Danshen formula myocardial ischemia reperfusion injury network pharmacology Pharmacology PI3K/Akt ventricular remodeling ventricular remodeling Guanxin Danshen formula network pharmacology myocardial ischemia reperfusion injury PI3K/Akt estrogen receptor β
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[This corrects the article DOI: 10.3389/fphar.2017.00777.].
Bibliography:	corrigendum ObjectType-Correction/Retraction-1 content type line 23 SourceType-Scholarly Journals-1 These authors have contributed equally to this work Edited and reviewed by: Michael Heinrich, University College London, United Kingdom
ISSN:	1663-9812 1663-9812
DOI:	10.3389/fphar.2024.1488968